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تكون احلصّيات الدقيقة يف حويصالت الرئة اهلوائية
حالة نادرة غالباً ما ُيطَأ يف تشخيصها
األكي�ض كورانا، راجي�ض ماليك، جيتندرا �شارما، اأوجوال كورانا، ديبتي جو�شي، ابي�شيك جويال
abstract: Pulmonary alveolar microlithiasis (PAM) is an uncommon entity which can pose a diagnostic challenge. 
We report a 45-year-old female who was referred to the All India Institute of Medical Sciences, Bhopal, India, in 2017 
with a two-year history of progressively worsening dyspnoea and dry coughing. She had been previously diagnosed with 
pulmonary tuberculosis elsewhere and prescribed antitubercular therapy; however, there was little improvement in her 
symptoms. Following referral, the patient was diagnosed with PAM based on high-resolution computed tomography 
findings and the abundance of lamellar microliths in a bronchoalveolar lavage sample. She was subsequently managed 
symptomatically and enrolled in a rehabilitation programme.
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الرئة الهوائية من احلالت املر�شية الغري �شائعة والتي متثل يف الغالب حتدًيا  امللخ�ص: يعترب تكون احل�شّيات الدقيقة يف حوي�شالت 
الهند للعلوم  اإىل معهد عموم  اأحيلت  45 عاًما  العمر  اأحد هذه احلالت والتي هي عبارة عن امراأة بالغة من  ت�شخي�شًيا، يتم هنا ت�شجيل 
الطبية يف مدينة بوبال يف الهند يف عام 2017 وهي تعاين منذ �شنتني من تدهور تدريجي يف �شيق التنف�ض و�شعال جاف، مت ت�شخي�ض 
ن الأعرا�ض طفيفًا، بعد معاينة  املراأة �شابقًا يف مكان اآخر مبر�ض ال�شل الرئوي وو�شف لها اآنذاك العالج امل�شاد لل�شل، ولكن كان حت�شُّ
املري�شة، مت ت�شخي�شها بالإ�شابة باحل�شّيات الدقيقة يف حوي�شالت الرئة الهوائية بناءاً على ما اأظهرته نتائج الت�شوير املقطعي عايل 
الدقة والك�شف عن وجود ح�شّيات دقيقة بوفرة يف عينة اإفرازات الق�شبات الهوائية، متَّ عالج املراأة عن طريق تخفيف الأعرا�ض واإدخالها 
يف برنامج اإعادة تاأهيل.
الكلمات املفتاحية: التكلُّ�ض؛ تكون احل�شّيات الدقيقة يف حوي�شالت الرئة الهوائية؛ ال�شل الرئوي؛ خطاأ الت�شخي�ض الطبي؛ تقرير حالة؛ الهند.
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Pulmonary alveolar microlithiasis (pam)is a rare pathological entity not commonly encountered in routine clinical practice.1 Affected 
patients are often initially misdiagnosed and may 
undergo unnecessary treatment, such as antitubercular 
therapy in tuberculosis-endemic countries.2 As such, 
clinicians, radiologists and pathologists should be made 
aware of this entity so as to ensure a correct diagnosis.
Case Report
A 45-year-old female was referred to the Outpatient 
Pulmonology Department of the All India Institute of 
Medical Sciences, Bhopal, India, in 2017 with prog-
ressively worsening dyspnoea and dry coughing over 
the past two years. There was no history of fever, 
anorexia or weight loss. She had previously undergone 
chest radiography at other centres and been diagnosed 
with pulmonary tuberculosis, for which she was pres-
cribed antitubercular therapy. However, as there was 
very little improvement in her symptoms, she was sub- 
sequently referred to the All India Institute of Medical 
Sciences. At referral, a chest X-ray of the patient 
showed a bilateral dense micronodular pattern with 
fine reticulation predominantly at the bases, with a 
‘sandstorm’-like appearance [Figure 1]. Similar findings 
were noted in serial radiographs from the previous 
year. Her total leukocyte count was 9,000/mm3, with a 
differential cell count of 56% neutrophils, 39% lympho- 
cytes, 4% monocytes and 1% eosinophils. Her haemo-
globin levels were 13.1 g/dL and there was no history of 
haemoptysis since the onset of the illness. Other investi- 
gations, namely serum electrolytes (i.e. sodium, 
potassium, calcium, phosphorus and magnesium), 
renal function and liver function tests, were all within 
normal limits.
Pulse oximetry indicated an oxygen saturation 
of 94% in room air. Pulmonary function tests yielded 
a classical restrictive pattern with a normal forced 
expiratory volume (FEV1)/forced vital capacity (FVC) 
ratio and reduced FEV1 and FVC measurements 
(percent predicted values of 101%, 49% and 49%, 
respectively). An electrocardiogram and two-dimen-
sional echocardiograph were essentially normal, with 
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mildly elevated pulmonary artery pressure and no 
evidence of valvular heart disease. A high-resolution 
computed tomography (CT) scan revealed extensive 
dense interlobular and intralobular septal thickening 
of the parenchymal window and dense microcalcif-
ication with a predominantly subpleural and peri- 
bronchial distribution, suggestive of pulmonary alveolar 
microlithiasis [Figure 2].
The next day, the patient underwent flexible bron- 
choscopy. Bronchoalveolar lavage (BAL) smears showed 
microliths, alveolar macrophages, ciliated columnar 
epithelial cells and multinucleate macrophage giant cells 
[Figure 3]. According to a differential cell count, the BAL 
sample consisted predominantly of alveolar macro- 
phages (91%). The microliths were spherical lamellate 
refractile fragile bodies which were predominantly 
extracellular and varied from 100–120 µm in size. There 
were between 2–12 nuclei in the multinucleate giant 
cells. A transbronchial lung biopsy (TBLB) showed sheets 
of foamy macrophages containing periodic acid-Schiff 
(PAS)-positive material in the subepithelium; however, 
no microliths were visible. The patient was subsequently 
diagnosed with PAM. Since a lung transplant was not 
feasible, she was managed symptomatically and enrolled 
in a rehabilitation programme. Her family was also 
screened for the disease using chest X-rays; however, 
no other cases were identified.
Discussion
PAM is a rare disease characterised by the widespread 
accumulation of minute calculi known as microliths 
in the lung parenchyma.1 The most likely aetiopatho-
genesis of the disease is a mutation in the solute carrier 
family 34 member 2 (SLC34A2) gene, which leads to 
the ineffective uptake of phosphate from the alveoli 
and, therefore, the accumulation of calcium phosphate 
crystals.3 In the most comprehensive review of this 
entity to date, Castellana et al. analysed 1,022 PAM cases 
reported worldwide and noted that the disease had 
a slight male preponderance and most patients were 
in their second or third decade of life.1 A total of 80 
patients were of Indian origin. A positive family history 
was reported in 37% of cases.1 In the current case, the 
patient was an Indian female in her fifth decade of life 
and had no family history of PAM or a similar illness. 
A diagnosis of PAM usually depends on the 
identification of various radiological and histopatho-
logical features. In particular, the radiographical appear- 
ance of the patient’s lungs corresponds to the increasing 
severity of the disease.4 During the first stage, the radio- 
 
Figure 1: Chest X-ray of a 45-year-old female showing a 
bilateral dense micronodular pattern with fine reticulation.
 
Figure 2: Computed tomography of the (A) lung window 
of a 45-year-old female showing diffuse dense interlobular 
and intralobular septal thickening with patchy ground 
glass opacities and (B) the mediastinal window showing 
diffuse microcalcification in both lungs with a subpleural 
and peribronchial distribution. Pleural and pericardial 
calcification (arrows) is also present.
 
Figure 3: A: Wright Giemsa stain at x400 magnification 
showing spherical concentrically lamellate refractile micro- 
liths*. B: Papanicolaou stain of a bronchoalveolar lavage 
sample at x400 magnification showing a microlith 
(arrowhead), alveolar macrophage (black arrow) and ciliated 
columnar epithelial cell (white arrow).
*The fine focusing of these bodies makes the background cells appear 
out of focus.
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Conclusion
Despite its rarity, there is a need to increase the index 
of suspicion of PAM among clinicians, radiologists 
and pathologists in order to avoid misdiagnosis and 
unnecessary treatment. This case emphasises the 
combined role of high-resolution CT and BAL analysis 
in the diagnosis, thus avoiding the need for invasive 
procedures such as an open lung biopsy.
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logical findings are precalcific, although this is ident-
ified very rarely. In the second stage, the lungs have 
a typical ‘sandy’ appearance, with scattered microliths 
and a delineated cardiac border.4 The density of the 
microliths then increases to obscure the cardiac borders 
in the third phase, before involving the pleura in the 
fourth phase, as noted in the current case.4 Despite 
these typical radiological features, it is not uncommon 
for patients to be misdiagnosed with tuberculosis, as 
in the present case, particularly in endemic areas.2 
Despite this, the coexistence of tuberculosis and PAM 
is rare.1 Other diseases associated with a miliary dissem- 
ination include sarcoidosis, pneumoconiosis, haemo-
siderosis, amyloidosis and mycosis. However, while 
the radiological appearance of calcifications are more 
intense in PAM cases, the symptoms of these other 
differential diagnoses are usually more severe.1
In order to confirm the diagnosis, a lung biopsy is 
required to demonstrate the presence of characteristic 
PAS-positive concentric calcareous lamellae around 
a central nucleus.1 The microliths should be differen-
tiated from psammoma bodies, indicative of a malignant 
condition; these are similar in structure but occur as 
part of the epithelial cell group or as small tissue 
fragments.5 While the analysis of BAL samples is often 
inconclusive, the cytological findings in the current case 
were very characteristic of PAM, demonstrating both 
microliths and multinucleate giant cells.6,7 However, 
the presence of microliths in the BAL fluid rather 
than in the TBLB specimen was unusual, particularly 
as the latter technique is usually more sensitive for 
diffuse lung disease.8 This may have been because 
of the blind nature of the technique. In general, less 
than 50% of PAM cases have positive TBLB findings.9 
However, pulmonary function tests may have a support- 
ive role by revealing a restrictive pattern, as seen in the 
present case.10
Once diagnosed, the course of the illness is variable 
and can either remain stable or become progressively 
worse, resulting in cor pulmonale.11 However, since the 
onset is insidious and the clinical course is generally 
quite slow, it can be difficult to definitively establish 
the onset of the disease. Furthermore, since the SLC-
34A2 gene is expressed in certain extrapulmonary 
tissues—including the testicles, kidneys, pancreas, 
intestines, breasts, ovaries, liver and prostate—some 
patients may also have extrapulmonary symptoms, 
such as infertility, azoospermia, haematuria and gall-
stones.11,12 Currently, no medical or genetic therapy 
is yet available, with chelating agents and therapeutic 
lung lavage reported to be ineffective.10 To date, lung 
transplantation is the only accepted treatment, with 
survival up to 15 years reported without recurrence.13
